GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Galenica Ltd. (CHIX:GALEz) » Definitions » Other Net Income (Loss)

Galenica (CHIX:GALEZ) Other Net Income (Loss) : CHF120 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Galenica Other Net Income (Loss)?

Galenica's Other Net Income (Loss) for the six months ended in Dec. 2023 was CHF8 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF120 Mil.

Galenica's quarterly Other Net Income (Loss) increased from Dec. 2022 (CHF4 Mil) to Jun. 2023 (CHF113 Mil) but then declined from Jun. 2023 (CHF113 Mil) to Dec. 2023 (CHF8 Mil).

Galenica's annual Other Net Income (Loss) increased from Dec. 2021 (CHF0 Mil) to Dec. 2022 (CHF9 Mil) and increased from Dec. 2022 (CHF9 Mil) to Dec. 2023 (CHF120 Mil).


Galenica Other Net Income (Loss) Historical Data

The historical data trend for Galenica's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galenica Other Net Income (Loss) Chart

Galenica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 8.51 120.45

Galenica Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.13 4.38 112.84 7.61

Galenica Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galenica Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Galenica's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Galenica (CHIX:GALEZ) Business Description

Traded in Other Exchanges
Address
Untermattweg 8, Bern, CHE, 3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is primarily operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners and suppliers.

Galenica (CHIX:GALEZ) Headlines

No Headlines